Insider · CIK 0002060594
Bumpus Namandje
Reports to the SEC for 1 company · SALT LAKE CITY, UT
Transactions
7
Companies
1
Filings
4
CIK
0002060594
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-18 | RXRXRECURSION PHARMACEUTICALS, INC.S Sale | −$12.6K |
| 2026-06-17 | RXRXRECURSION PHARMACEUTICALS, INC.A Award | — |
| 2026-06-03 | RXRXRECURSION PHARMACEUTICALS, INC.S Sale | −$15.5K |
| 2025-06-18 | RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-06-18 | RXRXRECURSION PHARMACEUTICALS, INC.A Award | — |
| 2025-03-17 | RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-03-17 | RXRXRECURSION PHARMACEUTICALS, INC.A Award | — |
Recent filings
- 4Bumpus Namandje0001601830-26-000082SEC(opens sec.gov)
- 4Bumpus Namandje0002060594-26-000003SEC(opens sec.gov)
- 4Bumpus Namandje0001601830-25-000108SEC(opens sec.gov)
- 4Bumpus Namandje0001601830-25-000048SEC(opens sec.gov)
Companies
Address
C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET
SALT LAKE CITY, UT, 84101